Stockscreener 앱 받기
2.45
3.38%
0.08
시간 외 거래:
2.08
-0.37
-15.10%
전일 마감가:
$2.37
열려 있는:
$2.37
하루 거래량:
2.93M
Relative Volume:
1.19
시가총액:
$831.61M
수익:
$775.09M
순이익/손실:
$-58.68M
주가수익비율:
-18.48
EPS:
-0.1326
순현금흐름:
$64.06M
1주 성능:
+2.94%
1개월 성능:
-4.30%
6개월 성능:
-42.35%
1년 성능:
-47.31%
1일 변동 폭
$2.35
$2.4894
1주일 범위
$2.255
$2.4894
52주 변동 폭
$2.10
$5.8099
Goodrx Holdings Inc Stock (GDRX) Company Profile
명칭
Goodrx Holdings Inc
전화
(855) 268-2822
주소
2701 OLYMPIC BOULEVARD, SANTA MONICA
Compare GDRX vs VEEV, TEM, BTSG, HQY, WAY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GDRX
Goodrx Holdings Inc
|
2.45 | 804.46M | 775.09M | -58.68M | 64.06M | -0.1326 |
|
VEEV
Veeva Systems Inc
|
176.46 | 28.90B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
53.71 | 10.31B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
40.80 | 7.27B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
75.56 | 6.48B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
24.40 | 4.84B | 906.14M | -52.62M | 89.62M | -0.3621 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-22 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-12-09 | 개시 | Barclays | Underweight |
| 2025-08-11 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-08-09 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-05-23 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-05-16 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2024-04-10 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-03-25 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-03-01 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-01-02 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2023-08-10 | 업그레이드 | DA Davidson | Neutral → Buy |
| 2023-07-31 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2022-12-01 | 개시 | Citigroup | Buy |
| 2022-11-04 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-08-12 | 개시 | DA Davidson | Neutral |
| 2022-06-10 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-06-06 | 재개 | BofA Securities | Buy |
| 2022-06-01 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-05-10 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-05-10 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-05-10 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2022-05-10 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-11 | 개시 | Wells Fargo | Equal Weight |
| 2022-04-07 | 개시 | Guggenheim | Buy |
| 2022-04-01 | 재개 | Credit Suisse | Neutral |
| 2022-03-15 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2022-03-01 | 재확인 | Barclays | Overweight |
| 2022-03-01 | 재확인 | BofA Securities | Neutral |
| 2022-03-01 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2022-03-01 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2022-03-01 | 재확인 | Evercore ISI | Outperform |
| 2022-03-01 | 재확인 | Goldman | Buy |
| 2022-03-01 | 재확인 | JP Morgan | Underweight |
| 2022-03-01 | 재확인 | RBC Capital Mkts | Outperform |
| 2022-03-01 | 재확인 | SVB Leerink | Outperform |
| 2022-01-07 | 개시 | Goldman | Buy |
| 2021-12-21 | 개시 | Stephens | Overweight |
| 2021-12-02 | 개시 | Jefferies | Buy |
| 2021-08-31 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2021-08-13 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2021-05-28 | 개시 | Robert W. Baird | Neutral |
| 2021-04-06 | 재개 | Evercore ISI | Outperform |
| 2021-01-25 | 개시 | Guggenheim | Buy |
| 2020-11-19 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-11-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-10-19 | 개시 | Barclays | Equal Weight |
| 2020-10-19 | 개시 | BofA Securities | Neutral |
| 2020-10-19 | 개시 | Citigroup | Buy |
| 2020-10-19 | 개시 | Cowen | Outperform |
| 2020-10-19 | 개시 | Credit Suisse | Outperform |
| 2020-10-19 | 개시 | Deutsche Bank | Hold |
| 2020-10-19 | 개시 | Goldman | Neutral |
| 2020-10-19 | 개시 | JP Morgan | Neutral |
| 2020-10-19 | 개시 | Morgan Stanley | Overweight |
| 2020-10-19 | 개시 | RBC Capital Mkts | Sector Perform |
| 2020-10-19 | 개시 | SVB Leerink | Outperform |
| 2020-10-19 | 개시 | UBS | Buy |
모두보기
Goodrx Holdings Inc 주식(GDRX)의 최신 뉴스
GoodRx Reports Fourth Quarter and Full Year 2025 Results - PharmiWeb.com
GoodRx (GDRX) Sees High Call Activity Ahead of Earnings - GuruFocus
GoodRx Holdings, Inc. (GDRX) Reports In-Line Q4 EPS ; Offers Guidance - StreetInsider
GoodRx Holdings, Inc. (GDRX) Investor Outlook: Exploring A Potential 100% Upside - DirectorsTalk Interviews
Employers get new way to cut Wegovy and GLP-1 costs with GoodRx - Stock Titan
GoodRx (GDRX) Reports Earnings Tomorrow: What To Expect - Finviz
GoodRx (GDRX): Buy, Sell, or Hold Post Q3 Earnings? - Finviz
LSV Asset Management Boosts Stock Position in GoodRx Holdings, Inc. $GDRX - MarketBeat
GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 11% Loss Last Week Hit Both Individual Investors Who Own 48% as Well as Institutions - 富途牛牛
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of GoodRx Holdings, Inc. (NASDAQ: GDRX) and Encourages Long-Term GDRX Investors to Contact the Firm - ACCESS Newswire
How Recent Analyst Shifts Are Rewriting The Story For GoodRx Holdings (GDRX) - Yahoo Finance
GoodRx (NASDAQ:GDRX) Trading Up 7.9%Should You Buy? - MarketBeat
GoodRx (NASDAQ:GDRX) Trading Down 6.4%Should You Sell? - MarketBeat
GoodRx (GDRX) Lifts Guidance as Pharma Partnerships Drive Double-Digit Growth - MSN
Is GoodRx (GDRX) Using ARAKODA Discounts To Quietly Redefine Its Preventive Care Strategy? - Yahoo Finance
GoodRx Holdings, Inc.'s (NASDAQ:GDRX) biggest owners are retail investors who got richer after stock soared 7.5% last week - simplywall.st
GoodRx (GDRX) Partners with Pfizer for Discounts on TrumpRx - GuruFocus
Headwinds in GoodRx’s (GDRX) Drug Prescription Business Draw Cautious View from Jefferies - Insider Monkey
GoodRx becomes pricing source for Pfizer and other drugmakers on TrumpRx - Seeking Alpha
GoodRx Says It's Key Integration Partner for TrumpRx Platform; Shares Up Pre-Bell - marketscreener.com
11 Best Stocks Under $3 to Buy Right Now - Insider Monkey
Pfizer cuts prices up to 85% on 30+ drugs via TrumpRx and GoodRx - Stock Titan
Amazon Is Now Offering Novo Nordisk's Wegovy Pill in Its Pharmacy. Here's How That Could Affect Hims & Hers, WW International, and GoodRx Holdings. - Yahoo Finance
Amazon Is Now Offering Novo Nordisk's Wegovy Pill in Its Pharmacy. Here's How That Could Affect Hims & Hers, WW International, and GoodRx Holdings. - The Motley Fool
GoodRx powers pricing for leading Brand Medications on TrumpRX - marketscreener.com
GoodRx stock climbs amid TrumpRx launch speculation By Investing.com - Investing.com Canada
GoodRx Holdings, Inc. (GDRX) Stock Analysis: Is A 100% Upside Within Reach? - DirectorsTalk Interviews
GoodRx (GDRX) to Offer Savings on Arakoda in New Partnership - GuruFocus
GoodRx system that saved Americans $100B earns key data safety seal - Stock Titan
Risk Report: Can GoodRx Holdings Inc expand its profit marginsQuarterly Profit Report & Accurate Buy Signal Alerts - baoquankhu1.vn
Published on: 2026-01-30 09:08:15 - baoquankhu1.vn
Universal Beteiligungs und Servicegesellschaft mbH Invests $3.04 Million in GoodRx Holdings, Inc. $GDRX - MarketBeat
GoodRx Announces Date for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call - Caledonian Record
GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring An 80% Upside Potential - DirectorsTalk Interviews
Is GoodRx Holdings Inc. showing insider buyingWeekly Investment Summary & Long-Term Safe Investment Ideas - mfd.ru
GoodRx (NASDAQ:GDRX) Hits New 1-Year LowShould You Sell? - MarketBeat
Q3 Earnings Highlights: GoodRx (NASDAQ:GDRX) Vs The Rest Of The Healthcare Technology Stocks - Finviz
GoodRx Holdings, Inc. (NASDAQ:GDRX) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Rate Hike: How does GoodRx Holdings Inc perform in inflationary periodsPortfolio Value Report & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Demystifying GoodRx Holdings: Insights From 8 Analyst Reviews - Benzinga
Weekly Recap: What is HBANLs revenue forecastGlobal Markets & Daily Profit Focused Stock Screening - baoquankhu1.vn
Activity Recap: Can GoodRx Holdings Inc deliver consistent EPS growthJuly 2025 Snapshot & Fast Gain Stock Trading Tips - baoquankhu1.vn
GDRX: Jefferies Downgrades GoodRx Holdings with Significant PT R - GuruFocus
Leerink Partners Remains Bullish on GoodRx Holdings (GDRX) - MSN
Jefferies downgrades GoodRx stock to Hold on prescription segment challenges - Investing.com
Jefferies Downgrades GoodRx Holdings Inc. (GDRX) to Hold - StreetInsider
GoodRx Users Denied Nod For $32M Deal In Data Sharing Row - Law360
Valuation Update: Whats the MACD signal for GoodRx Holdings Inc2025 Market Overview & Smart Swing Trading Alerts - baoquankhu1.vn
GoodRx’s $32 Million Info-Sharing Deal Fails to Get Court Nod - Bloomberg Law News
GoodRx Holdings, Inc.'s (NASDAQ:GDRX) last week's 6.9% decline must have disappointed individual investors who have a significant stake - Yahoo Finance
GoodRx Holdings, Inc. (NASDAQ:GDRX) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? - simplywall.st
Goodrx Holdings Inc (GDRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.01%
3.29%
자본화:
|
볼륨(24시간):